The Empty Code Cart, and the Empty Pharmacy Behind It

You have never once had to wonder whether the medicine that would save your life would be on the shelf when you reached for it. That was never luck, and it was never the free market. It was a machine — built on purpose, run by the people you've been taught to dismiss as bureaucrats and pencil-pushers — and right now that machine is being taken apart on purpose. The first place the damage shows is in the bodies of women.

Here is the part almost no one says out loud: the drugs disappearing from American hospitals are not the expensive, cutting-edge ones. They are the cheapest, oldest, plainest medicines we have — penicillin, magnesium, the shot that stops a hemorrhage, the shot that protects the next baby. We have had them for decades. They cost pennies. And for the women who need them, there is no substitute. Cheap, essential, irreplaceable, and vanishing all at once — that combination is the tell. Medicine does not disappear like that on its own. Someone has to stop watching. Someone has to decide it does not matter.

This week's Signal made that case about two drugs in the delivery room. This Briefing widens the lens, because the empty code cart is only one shelf in a building full of them. Walk it with me.

The same emptiness, five rooms deep.

In the delivery room, a woman with severe preeclampsia needs magnesium — the drug that for half a century has kept women from seizing and dying. It is the one obstetric drug in formal active shortage right now, rationed out a week at a time.^[1] If she also hemorrhages — and preeclampsia makes that more likely — the cheap front-line drugs that stop the bleeding may not be on the shelf either, and the fallbacks can cause a stroke in a woman with high blood pressure, or an attack in a woman with asthma.^[2][3] Even the rescue form of magnesium — the injection meant to live in every crash cart because it works "anywhere there is a body and a syringe" — is, in many hospitals, simply not in the building.^[4]

In the syphilis clinic, the only drug that cures syphilis in pregnancy and keeps the baby from being born with it — penicillin, which we have had since the 1940s — is in such deep shortage that the FDA is importing it from overseas and the CDC is openly rationing what's left: save it for pregnant women, give everyone else something weaker.^[6][7][8] This is happening while congenital syphilis has exploded — up 755% in a decade — and the CDC says nearly nine in ten of those sick babies could have been spared with timely treatment.^[9]

A country that has decided to test every pregnant woman for syphilis and cannot reliably stock the one drug that treats it has decided, by omission, which babies are born sick.

In the cancer ward, the platinum chemotherapy at the center of curing cervical and ovarian cancer ran short after a single factory in India failed a single inspection. One plant, one country, one bad inspection — and the cancer care of American women was rationed for three years and counting.^[10][11]

At the pharmacy counter, methotrexate — the standard treatment for an ectopic pregnancy, which will kill a woman if it is not ended — got hit from both sides at once: the same factory shutdown that took the chemotherapy, and, after Dobbs, pharmacists in some states permitted to refuse to fill it because it can also end a pregnancy.^[10][12] A time-critical, potentially fatal diagnosis, meeting a pharmacist's hesitation stacked on top of a manufacturer's shortage.

At the twenty-eight-week visit, RhoGAM — the shot that stops an Rh-negative mother's body from turning on her next pregnancy, a product with no substitute at all — is short enough that ACOG has had to tell doctors which dose to skip.^[13][14]

Five different rooms. One mechanism. The same cheap, off-patent, irreplaceable drugs, vanishing the same way — and because shortages get rationed by a hospital's past purchasing, the small and rural hospitals, the more than 1,100 counties already classified as maternity-care deserts, are cut off first.^[5]

Why the shelf was ever full.

Most of us picture drug supply as something simple: a company makes a medicine, a pharmacy sells it. It is nothing like that. It is a chain in which the government is load-bearing at every single link — the FDA inspecting the factories, the CDC tracking the diseases that drive demand, CMS setting the payments that decide whether a rural hospital can keep magnesium on hand and whether any company will bother to make a drug that earns pennies. When a plant overseas falsifies its data, it is an FDA inspector who shuts it down. When there are not enough inspectors, it does not get shut down in time.^[15]

It was never magic. It was a person you will never meet, doing a job the people now in power call worthless.

That is the machine: an unglamorous apparatus of inspectors, analysts, and supply monitors, built so that the rest of us would never have to think about any of it — so you could reach for the medicine and simply trust that it would be there. The people who run it are exactly the ones we have spent a generation being trained to sneer at — the bureaucrats, the regulators, the pencil-pushers, the "waste." They are the reason the shelf was full. And the market will not save any of it: these drugs are generic, off-patent, and cheap, so no one gets rich making them, and a drug that had three makers quietly drops to two, then one, then none.^[16] This is a market that fails toward scarcity on its own. Only the machine — the inspectors, the payments, the reserves — can hold it up.

The free market, left to itself, does not solve this problem — it is the problem.

It was built on purpose. It is being taken apart on purpose.

Someone built that machine, and it is worth remembering who. The last president to gather executive power on anything like the scale we are watching now was Franklin Roosevelt — four terms, more authority than any president before him, in a decade when leaders across the world were using exactly that kind of crisis to crown themselves dictators. He had every excuse to do the same. He built instead: the New Deal, the administrative state beneath it, and the postwar order — the United Nations, the alliances, the institutions that anchored the longest run of broad prosperity the modern world has known.

No one is claiming that order was flawless, or that everything done in its name was good. It was not. But the ledger is not close. By the measures that matter — how long we live, how stable our lives are, how many ordinary catastrophes simply stopped happening — the system Roosevelt set in motion has done far more good than harm, and it has done it for Americans most of all.

So when you look at the real inequality and dysfunction in this country, the reflex is to blame the machine — the bureaucracy, the regulators. That reflex is exactly backwards. The inequality was not built by the people who run the machine. It was built by the people working to tear it down — because tearing things down is the entire project. The same movement dismantling the administrative state is the one unwinding the global order, gutting the Civil Rights Act, working to push women back into the home, stripping away reproductive rights. It is one project, and it is perfectly consistent.

The shortage is not a glitch in the system. It is the system being taken apart — on schedule, and on purpose.

That is what the empty shelf actually is. Not bad luck, not bad weather, but a manufactured result — the predictable consequence of starving the machine that kept the shelf full, cut from the same cloth as everything else this movement touches, at home and abroad. Which brings us to the people they have put in charge of it.

And who is minding the shelf? A vaccine skeptic and a TV doctor.

The agency that oversees the FDA, the CDC, and the entire apparatus of drug safety — the Department of Health and Human Services — is run by a man with no training in medicine, pharmacology, or public health, who has spent his career questioning vaccines and the motives of the drug industry. Its attention has gone to vaccine exemptions, to stripping warnings off hormone therapy, to studying whether to withhold the hepatitis B shot from newborns. This is an HHS that has decided the drug industry's great sin is making too many vaccines — not failing to make enough penicillin.

And the agency that holds the money — CMS, the one body that could pay manufacturers to stay in the market and pay hospitals to keep a buffer stock — is now run by Dr. Mehmet Oz: a real physician, yes, but one whose national brand was built on daytime-television supplements, and whose credibility for this particular job is compromised rather than earned.^[17] The single most concrete tool we have for keeping essential medicines on the shelf — a buffer-stock payment CMS has already finalized — now sits in his hands.^[18]

The vaccine skeptic sets the priorities. The TV doctor controls the money. Neither one is paying attention to penicillin.

The same administration that frets aloud about falling birth rates has presided over a surge in sterilizations among young women — many who have never had children — who no longer trust the country to let them manage a pregnancy safely. You do not get more babies by stripping women of control over their own bodies. You get more women who decide not to risk it — in a country that cannot reliably stock the drugs a pregnancy requires.

What we took for granted, we cannot anymore.

The tools to fix this exist — a federal drug-shortage prevention bill, a CHIPS-style program to make these generics on American soil again, Medicaid pricing reform, and the buffer-stock payment already on the books.^[18] Every one of them is gated on a Congress the 2026 midterm will decide. None of them are on this HHS's agenda.

So this is not a drug-pricing story, and it is not a free-market problem the free market will solve. It is a question of who still counts as worth keeping in stock — and whether the people holding the inspectors, the payments, and the priorities are paying any attention at all. What we once took for granted, we can take for granted no longer — not because the medicine got harder to make, but because the people now in charge do not believe in the work that kept it within reach.